Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer
Highlights •Identified an allosteric pocket at the CDC42/RHOJ effector interaction interface •Used in silico methods to identify and optimize ARN22089, which binds to CDC42 •ARN22089 has broad